Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Sponder is active.

Publication


Featured researches published by Michael Sponder.


Vascular Health and Risk Management | 2014

Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease

Michael Sponder; Monika Fritzer-Szekeres; Rodrig Marculescu; Martina Mittlböck; Maria Uhl; Birgit Köhler-Vallant; Jeanette Strametz-Juranek

Background Heavy metal pollutants such as cadmium (Cd), lead (Pb), and mercury (Hg) are rarely the subjects of cardiovascular research although they have been suspected for decades to negatively impact the circulatory system. Methods Apart from detailed anamnestic data, urinary levels of Cd and full blood levels of Pb and Hg were measured in 53 female (mean age: 68.04±7.03 years) and 111 male (mean age: 60.68±11.43 years) nonsmoking or never-smoking patients with angiographically verified and precisely quantified coronary artery disease (CAD). Results Although Cd was quantifiable in 68.3% of subjects, only 34.1% of these patients exceeded the critical 1 μg/L Human Biomonitoring (HBM)-I level. Median Pb (20 μg/L) and Hg (0.55 μg/L) levels were lower than the HBM-I, as well as reference levels of Pb. Wine consumption was the main source for Pb, fish and wine consumption for Hg, and previous nicotine abuse for Cd. There was no correlation between Cd, Pb, or Hg and severity of CAD although severity correlated positively with atherosclerosis parameters (uric acid, creatinine, triglycerides, blood urea nitrogen, C-reactive protein) and negatively with high density lipoprotein cholesterol. Conclusion Cd levels detected in CAD patients were high compared to German and European reference levels but it could not be proven that urine levels of Cd and blood levels of Hg or Pb played a major role in the genesis of CAD, particularly when compared to well-known biomarkers such as blood pressure, glucose, and lipids.


Vascular Health and Risk Management | 2014

A new coronary artery disease grading system correlates with numerous routine parameters that were associated with atherosclerosis: a grading system for coronary artery disease severity.

Michael Sponder; Monika Fritzer-Szekeres; Rodrig Marculescu; Brigitte Litschauer; Jeanette Strametz-Juranek

Background Several scoring systems have tried to determine the severity of coronary artery disease (CAD) to investigate the connection between CAD severity and laboratory parameters. Methods In total, 189 male (mean age: 61.86±10.77 years) and 75 female CAD patients (mean age: 67.84±7.70 years) were recruited and underwent angiography, which determined stenosis grade, of 17 coronary segments: no points for each nonstenosed segment or only calcified segments, one point for each stenosis from <30% to <50%, two points for each stenosis from 50% to <70%, and three points for each stenosis >70%. The points were added and should represent the severity of patients’ CAD. Results The coronary score correlated positively with systolic blood pressure, creatinine, blood urea nitrogen, lipase, glucose, glycated hemoglobin, triglycerides, C-reactive protein, fibrinogen Clauss, and leukocytes, and correlated negatively with Cl−, iron, and high-density lipoprotein cholesterol. Stepwise multiple regression analysis with backward elimination revealed diabetes status, sex, and fibrinogen Clauss as significant predictors of coronary score. Conclusion The coronary score delivers a quite simple but very precise tool for the quantification of CAD severity. These results show plainly the connection between CAD severity and the lipid, glucose, coagulation, and immunologic status of CAD patients, and substantiate the importance of sufficient treatment in this group of patients – in particular, CAD patients suffering from type 2 diabetes mellitus. The coronary score would offer a suitable tool for the investigation of the connection between CAD and new biomarkers. Further studies are needed to investigate the correlation of the coronary score with outcome parameters (eg, death).


Cardiovascular Diabetology | 2014

Exercise increases serum endostatin levels in female and male patients with diabetes and controls.

Michael Sponder; Daniela Dangl; Stephanie Kampf; Monika Fritzer-Szekeres; Jeanette Strametz-Juranek

BackgroundType 2 diabetes mellitus (T2DM) is often associated with atherosclerotic changes in coronary vessels, most notably plaques. The angiostatic parameter endostatin is able to inhibit angiogenesis in tissue as well as in plaques and therefore plays an important role in physiological and pathological neovascularisation. The aim of the present study was to investigate sex-specific differences and the influence of exercise on circulating endostatin levels in patients suffering from diabetes, and control subjects.MethodsIn total, 42 T2DM-patients and 45 control subjects were investigated. They underwent a graded physical stress test (ergometry). Serum endostatin levels were measured in venous blood at rest and directly after reaching maximum workload.ResultsFemales showed significantly higher endostatin levels at baseline measurements compared to men, independently of their underlying disease. In both female and male T2DM-patients endostatin levels were significantly lower compared to controls. Both groups and sexes showed a significant increase of endostatin after physical stress, whereas the extent of endostatin-increase was between 10.59-15.05%.ConclusionMiddle-aged healthy female individuals as well as female T2DM-patients showed higher circulating serum endostatin levels compared to males, suggesting a hormonal influence on baseline circulating endostatin amounts. Exercise-induced increase in endostatin is also observable in patients suffering from T2DM. Concerning vascularisation, lower endostatin levels in T2DM might be advantageous. Concerning plaque stability, lower levels might be prejudicial.Trial registrationClinical Trial Registration-URL: http://clinicaltrials.gov/ct2/results?term=NCT01165515


International Journal of Sports Medicine | 2014

Endostatin and Physical Exercise in Young Female and Male Athletes and Controls

Michael Sponder; K. Sepiol; S. Lankisch; M. Priglinger; Stephanie Kampf; Brigitte Litschauer; Monika Fritzer-Szekeres; Jeanette Strametz-Juranek

It was suggested that endostatin, an angiogenic mediator, is influenced by physical exercise. We performed bicycle stress testing in 88 healthy non-smoking female and male individuals, divided into athlete and non-athlete groups. Serum endostatin and norepinephrine were measured at rest, after reaching maximum workload and after 20 min of recovery. At baseline, both female and male controls showed significant lower levels compared to female and male athletes (89.39±15.32 resp. 93.39±15.00 ng/ml; p<0.001 vs. 128.81±20.84 resp. 147.52±27.72; p<0.001). An increase in endostatin levels in both groups and sexes was associated with bicycle stress testing (p for all groups<0.001). The extent of endostatin increase was comparable in both groups and sexes and varied between 23-27%. Significance was obscured when the performance was entered as covariate. Acutely induced physical strain leads to an increase in endostatin levels in athletes and controls of both sexes, the extent of increase depending on the extent of workload. An athletic lifestyle with >3 h of endurance training/week seems to lead to higher long-term endostatin levels which might play a role in the connection between sports and cardiovascular prevention.


Journal of Sports Sciences | 2017

Long-term endurance training increases serum cathepsin S and decreases IL-6 and hsCRP levels

Michael Sponder; Ioana-Alexandra Campean; Michael Emich; Monika Fritzer-Szekeres; Brigitte Litschauer; Jutta Bergler-Klein; Senta Graf; Jeanette Strametz-Juranek

ABSTRACT Cathepsin S (CS) was shown to play a key role in cancer progression, atherosclerosis, heart valve disease, insulin resistance and diabetes mellitus. The present prospective study aimed to investigate the influence of sports on CS, interleukin-6 (Il-6) and high-sensitivity C-reactive protein (hsCRP) levels. Ninety-eight of 109 participants completed the study. Ergometries were performed at baseline and after 8 months to evaluate/quantify the performance gain. Blood samples were taken at baseline and every 2 months. CS was measured by ELISA (enzyme-linked immunosorbent assay). Compared to the control group (mean performance gain −3.41 ± 4.62%) we observed a significant physical-activity-induced increase of CS levels (3.45–3.73 ng · ml−1; P = 0.027) and a significant decrease of Il-6 (2.43–1.91 pg · ml−1; P = 0.031) and hsCRP-levels (0.11–0.09 mg · dl−1; P = 0.001) in the intervention group (mean performance gain: 12.13 ± 6.32%). Furthermore, the tendency of the progression was significant for CS and Il-6 (P = 0.002/0.033). We could show a significant sports-induced decrease of the classic inflammation parameters hsCRP/Il-6, probably expressing a downregulation of permanently prevalent inflammation processes. Simultaneously CS levels increased significantly. Our results show that increasing CS amounts are not simply to equal with an enhanced inflammation status and might even have beneficial effects on inflammation and angiogenesis.


European Journal of Internal Medicine | 2018

Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) – A nationwide multicentre registry

Michael Sponder; Cesar Khazen; Wolfgang Dichtl; Lukas Fiedler; Deddo Mörtl; Alexander Teubl; Clemens Steinwender; Martin Martinek; Michael Nürnberg; Daniel Dalos; Johannes Kastner; Christoph Schukro

Background Subcutaneous implantable cardioverter-defibrillators (S-ICD) are an innovative and less invasive alternative to transvenous ICD (TV-ICD) in selected patients. We aimed to investigate the underlying diseases and the specific indications for implanting S-ICD in clinical practice, as well as the prevalence of shock delivery and complications.BACKGROUND Subcutaneous implantable cardioverter-defibrillators (S-ICD) are an innovative and less invasive alternative to transvenous ICD (TV-ICD) in selected patients. We aimed to investigate the underlying diseases and the specific indications for implanting S-ICD in clinical practice, as well as the prevalence of shock delivery and complications. METHODS AND RESULTS From December 2012, data of 236 patients (30,5% female; age 48,6±16,8years) were gathered from 12 centres in Austria. Follow-up data over a period of 1,7±1,1years were available for 231 patients (in total 359,2 patient-years). Predominant underlying diseases were ischemic cardiomyopathy (iCMP; 32,0%), idiopathic ventricular fibrillation (22,6%) and dilated cardiomyopathy (dCMP; 17,3%). The most frequent indications for implantation were sudden cardiac death survival (27,4%), primary prevention for iCMP (23,9%) and for dCMP (12,8%), and previous explantation of TV-ICD (12,4%). Appropriate shocks were documented in 16 patients (6,9%), iCMP being the predominant underlying disease. Arrhythmia conversion was successful in all patients, efficacy of the first shock was 96%. Inappropriate shock rate was 5,2%, predominantly caused by oversensing of T wave or artefacts. A device upgrade to an ICD system with pacing function was necessary in <1%. Clinical complications needing surgical revision occurred in 8 patients (3,5%). CONCLUSIONS S-ICD were mostly implanted for primary prevention, one fourth of our cases were sudden death survivors. Clinical and functional complication rate was relatively low. In conclusion, S-ICD is a safe and efficient alternative in a larger population of ICD candidates, when no cardiac pacing is needed. EC-number: C-136-17.


International Journal of Medical Sciences | 2017

Sports and HDL-Quality Reflected By Serum Amyloid A and Surfactant Protein B

Michael Sponder; Chantal Kopecky; Ioana-Alexandra Campean; Michael Emich; Monika Fritzer-Szekeres; Brigitte Litschauer; Senta Graf; Marcus D. Säemann; Jeanette Strametz-Juranek

Background: The aim of this prospective study was to investigate the influence of long-term physical activity on HDL quality, reflected by serum amyloid A (SAA) and surfactant protein B (SPB). Methods and results: 109 healthy subjects were recruited, 98 completed the study. Participants perform within the calculated training pulse for 8 months. The performance gain was measured/quantified by bicycle stress tests at the beginning and end of the observation period. SAA and SPB were measured at baseline and after 4 and 8 months by ELISA. In contrary to HDL-quantity, there was no sports-induced change in SAA or SPB observable. However, significant predictors for SPB-levels were smoking status, BMI and weekly alcohol consumption and for SAA weekly alcohol consumption together with sex and hsCRP-levels. Conclusions: Long-term physical activity increases HDL-quantity but has no impact on HDL-quality reflected by SAA and SPB. Smoking is associated with higher SPB-levels and the weekly alcohol intake is associated with both higher SAA and SPB-levels suggesting a damaging effect of smoking and drinking alcohol on the HDL-quality. We assume that HDL-quality is at least as important as HDL-quantity when investigating the role of HDL in (cardiovascular) disease and should receive attention in further studies dealing with HDL.


BMC Cardiovascular Disorders | 2017

Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study

Michael Sponder; Ioana-Alexandra Campean; Michael Emich; Monika Fritzer-Szekeres; Brigitte Litschauer; Jutta Bergler-Klein; Senta Graf; Jeanette Strametz-Juranek

AbstractsBackgroundEndocan (EN) was suggested a potential inflammatory and cardiovascular disease (CVD) marker which might also be involved in renal failure and/or renal failure-associated vascular events. It is not clear whether osteoprotegerin (OPG) is a pro- or anti-atherogenic factor, however, it is agreed upon that OPG is elevated in subjects with increased calcification status. The aim of the study was to investigate the influence of long-term physical activity on serum endocan (EN) and osteoprotegerin-levels.MethodsOne hundred nine subjects were told to increase their amount of physical activity for 8 months by performing 150min/week moderate or 75min/week vigorous exercise. Incremental cycle ergometer tests were performed at the beginning and the end of the study to prove and quantify the performance gain. Blood samples were drawn at baseline and every 2 months for the determination of EN and OPG. To investigate the difference between baseline and 8 months levels of EN and OPG we used a paired sample t-test. To investigate the significance of the tendency of the progression (baseline/2 months/4 months/6 months/8 months) we used a Friedman test.ResultsThirty-eight female and 60 male subjects completed the study. In the group of 61 subjects who had a performance gain by >4,9% EN-levels increased from 146 ± 110 to 196 ± 238 pg/ml (p = 0,036) equivalent to an increase of 33,5% but there was no significant change in OPG (4,4 ± 2,4 pmol/l vs. 4,3 ± 2,1 pmol/l; p = 0,668).ConclusionsPhysical activity increases significantly EN-levels relativizing the status of EN as proinflammatory factor. EN should rather be considered as a mediator which is involved in several physiological (e.g., angiogenesis) but also pathological processes (e.g., CVD, tumour progression or endothelium-dependent inflammation) and whose expression can be significantly influenced by long term endurance training.Trial registrationClinical trial registration number: NCT02097199 Date of trial registration at Clinical Trials.gov: 24.03.2014; last update: 6.1.2016


Journal of general practice | 2014

Influence of Migration Status and Gender on Awareness of Cardiovascular Risk Factors and Cardiovascular Health in a Group of Turkish Immigrants and Indigenous Austrians

Teresa Haidinger; Michael Sponder; Lena Stütz; Dondue Demir; Alex; ra Kaider; Jeanette Strametz-Juranek

Background: The aim of this study was to investigate differences in the awareness of cardiovascular risk factors, preventive action taken and barriers to cardiovascular health between the Turkish minority living in Austria and the indigenous people. Methods: A total of 1800 anonymous questionnaires were handed out to 573 women and 336 men with no immigration background and compared with 257 female and 250 male Turkish migrants in Turkish language living in Austria. Results: Cardiovascular disease was more likely to be identified as the leading cause of death by indigenous Austrians (75%) than by the Turkish participants. Diabetes mellitus II (DM II) was only identified by around 27% of the Austrians and 22% of the Turkish women and 28% of the Turkish men. Albeit Austrians can identify more risk factors and have a lower actual CVD risk, their main barrier to CVD health being the inability to assess their personal risk correctly, while Turkish immigrants show a lack of knowledge of how to access preventive screening. Conclusion: The main barrier for preventive action for the Turkish minority is a low educational and acculturation level, while Austrian women in particular have difficulties in assessing their personal risk correctly.


European Journal of Internal Medicine | 2017

Specific indications and clinical outcome in patients with subcutaneous ICD – A nationwide multicentre registry

Michael Sponder; Cesar Khazen; Wolfgang Dichtl; Lukas Fiedler; Deddo Mörtl; Alexander Teubl; Clemens Steinwender; Martin Martinek; Michael Nürnberg; Daniel Dalos; Johannes Kastner; Christoph Schukro

Background Subcutaneous implantable cardioverter-defibrillators (S-ICD) are an innovative and less invasive alternative to transvenous ICD (TV-ICD) in selected patients. We aimed to investigate the underlying diseases and the specific indications for implanting S-ICD in clinical practice, as well as the prevalence of shock delivery and complications.BACKGROUND Subcutaneous implantable cardioverter-defibrillators (S-ICD) are an innovative and less invasive alternative to transvenous ICD (TV-ICD) in selected patients. We aimed to investigate the underlying diseases and the specific indications for implanting S-ICD in clinical practice, as well as the prevalence of shock delivery and complications. METHODS AND RESULTS From December 2012, data of 236 patients (30,5% female; age 48,6±16,8years) were gathered from 12 centres in Austria. Follow-up data over a period of 1,7±1,1years were available for 231 patients (in total 359,2 patient-years). Predominant underlying diseases were ischemic cardiomyopathy (iCMP; 32,0%), idiopathic ventricular fibrillation (22,6%) and dilated cardiomyopathy (dCMP; 17,3%). The most frequent indications for implantation were sudden cardiac death survival (27,4%), primary prevention for iCMP (23,9%) and for dCMP (12,8%), and previous explantation of TV-ICD (12,4%). Appropriate shocks were documented in 16 patients (6,9%), iCMP being the predominant underlying disease. Arrhythmia conversion was successful in all patients, efficacy of the first shock was 96%. Inappropriate shock rate was 5,2%, predominantly caused by oversensing of T wave or artefacts. A device upgrade to an ICD system with pacing function was necessary in <1%. Clinical complications needing surgical revision occurred in 8 patients (3,5%). CONCLUSIONS S-ICD were mostly implanted for primary prevention, one fourth of our cases were sudden death survivors. Clinical and functional complication rate was relatively low. In conclusion, S-ICD is a safe and efficient alternative in a larger population of ICD candidates, when no cardiac pacing is needed. EC-number: C-136-17.

Collaboration


Dive into the Michael Sponder's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Brigitte Litschauer

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Daniel Dalos

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Senta Graf

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Michael Emich

United Kingdom Ministry of Defence

View shared research outputs
Top Co-Authors

Avatar

Christoph Schukro

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Jutta Bergler-Klein

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Wolfgang Dichtl

Innsbruck Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge